Cell ReportsNeurosciencePeer-reviewed journal article
Stasimon contributes to the loss of sensory synapses and motor neuron death in a mouse model of spinal muscular atrophy
Christian M. SimoniD, Meaghan Van AlstyneiD, Francesco LottiiD, Elena BianchettiiD, Sarah Tisdale, Daniel Martin WattersoniD, George Z. MentisiD, Livio PellizzoniiD
Abstract
Reduced expression of the SMN protein causes spinal muscular atrophy (SMA) - an inherited neurodegenerative disease characterized by multiple synaptic deficits and motor neuron loss. Here, we show that AAV9-mediated delivery of Stasimon - a gene encoding an ER-resident transmembrane protein regulated by SMN - improves motor function in a mouse model of SMA through multiple mechanisms. In proprioceptive neurons of SMA mice, Stasimon overexpression prevents the loss of afferent synapses on motor neurons and enhances sensory-motor neurotransmission. In SMA motor neurons, Stasimon suppresses the neurodegenerative process by selectively reducing phosphorylation but not upregulation of the tumor suppressor p53, both of which are converging events required to trigger neuronal death. We further show that Stasimon deficiency synergizes with SMA-related mechanisms of p53 upregulation to induce phosphorylation of p53. These findings identify Stasimon dysfunction induced by SMN deficiency as an upstream driver of cellular pathways that lead to synaptic loss and motor neuron degeneration, revealing a dual contribution of Stasimon to motor circuit pathology in SMA.
- Citations
- 64
- FWCI
- 4.26
- Field percentile
- top 5%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neuromuscular denervation and deafferentation but not motor neuron death are disease features in the Smn 2B/- mouse model of SMA
Maria Jose Carlini, Marina K Triplett, Livio Pellizzoni·PLoS ONEPeer-reviewed·Aug 1, 2022
- Diminished motor neuron activity driven by abnormal astrocytic GLAST glutamate transporter activity in spinal muscular atrophy is not fully restored after lentiviral SMN delivery
Emily Welby, Allison D. Ebert·bioRxiv·May 30, 2022
- Depletion of SMN Protein in Mesenchymal Progenitors Impairs the Development of Bone and Neuromuscular Junction in Spinal Muscular Atrophy
Sang‐Hyeon Hann, Seon-Yong Kim, … Young‐Yun Kong·eLifePeer-reviewed·Nov 7, 2023
- A p53-ΔNp73 signaling axis drives selective motor neuron degeneration in spinal muscular atrophy
Maria Jose Carlini, Xuemei Hu, … Livio Pellizzoni·bioRxiv·Jun 25, 2026
- A chemical screen identifies p38 MAPK inhibition as a candidate neuroprotective strategy for combinatorial SMA therapy
Maria Jose Carlini, Jorge Espinoza‐Derout, … Livio Pellizzoni·bioRxiv·Mar 6, 2025
- Synaptic imbalance and increased inhibition impair motor function in SMA
Emily V. Fletcher, Joshua I. Chalif, … George Z. Mentis·Science AdvancesPeer-reviewed·Sep 5, 2025